Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $CHRO
Channel Therapeutics Corporation
Subscribe to $CHRO
$CHRO
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
IPO Year: 2024
Exchange: AMEX
Recent Analyst Ratings for Channel Therapeutics Corporation
Date
Price Target
Rating
Analyst
See more ratings
